Cold-stored leukoreduced CPDA-1 whole blood: in vitro quality and hemostatic properties
Open Access
- 1 May 2020
- journal article
- research article
- Published by Wiley in Transfusion
- Vol. 60 (5), 1042-1049
- https://doi.org/10.1111/trf.15748
Abstract
BACKGROUND Some jurisdictions require leukoreduction of cellular blood components. The only whole blood collection set with a platelet-saving filter uses citrate-phosphate-dextrose (CPD) as storage solution. Substituting CPD with citrate-phosphate-dextrose-adenine (CPDA-1) increases shelf life from 21 to 35 days. This would simplify prehospital and rural resupply and reduce wastage. We investigated in vitro quality and hemostatic properties of CPDA-1 whole blood leukoreduced with a platelet-saving filter. STUDY DESIGN AND METHODS CPDA-1 whole blood was leukoreduced using a platelet-saving filter and stored 35 days. EDQM requirements, hematology, metabolic parameters, thromboelastography, light transmission aggregometry, fibrinogen, factor VIII, and interleukin-6 were measured on Days 0, 1, 14, 21, and 35 and compared to non-leukoreduced blood. RESULTS All units met EDQM requirements. Leukoreduction yielded residual white blood cell count 0.8% was observed. Factor VIII was higher on Day 35 in the leukoreduced group, 37.9 (95% CI: 26.0, 49.8) versus 13.8 (9.4, 18.2) IU/dL. In both groups, aggregation was significantly reduced by Day 14. Thromboelastography showed remaining platelet activity on Day 35, MA 46.9 (42.1, 51.7) in the leukoreduced and 44.3 (39.6, 49.0) mm in the non-leukoreduced group. Fibrinogen was within reference ranges at Day 35 (>2 g/dL). Interleukin-6 was not detectable. CONCLUSION Leukoreducing CPDA-1 whole blood with a platelet-saving filter did not compromise hemostatic properties. We encourage development of a single bag CPDA-1 whole blood collection set with in-line platelet-saving filter.This publication has 27 references indexed in Scilit:
- In vitro function of platelet concentrates prepared after filtration of whole blood or buffy coat poolsVox Sanguinis, 2005
- Multicenter evaluation of a whole-blood filter that saves plateletsTransfusion, 2004
- Evaluation of a new whole-blood filter that allows preparation of platelet concentrates by platelet-rich plasma methodsTransfusion, 2003
- Cytokine Generation in Whole Blood, Leukocyte-Depleted and Temporarily Warmed Red Blood Cell ConcentratesVox Sanguinis, 1999
- Time‐dependent, spontaneous release of white cell‐ and platelet‐derived bioactive substances from stored human bloodTransfusion, 1996
- Febrile reactions to platelet transfusion: the effect of increased interleukin 6 levels in concentrates prepared by the platelet‐rich plasma methodTransfusion, 1996
- The Role of the Plasma from Platelet Concentrates in Transfusion ReactionsThe New England Journal of Medicine, 1994
- Viability and function of red blood cell concentrates stored at 4 degrees C for 35 days in CPDA‐1, CPDA‐2, or CPDA‐3Transfusion, 1982
- Red blood cell concentrates stored at 4 degrees C for 34 days in CPDA- 1, CPDA-2, or CPDA-3 anticoagulant-preservative, biochemically modified, and frozen and stored in the polyvinyl chloride plastic primary collection bag with 40% W/V glycerol at -80 degrees CTransfusion, 1982
- Adenine Blood PreservationCRC Critical Reviews in Clinical Laboratory Sciences, 1981